The treatment landscape for non-small cell lung cancer (NSCLC) is constantly evolving. New FDA approvals and evolving National Comprehensive Cancer Center (NCCN) guidelines means it is more important than ever for clinicians to understand clinical trial data, emerging agents, current agents, and current guideline recommendations to provide the most appropriate and effective treatments for their patients. HOPE Learning Center includes a variety of CME activities to help busy clinicians stay abreast of these changes and support their ability to provide optimal patient care.